Stem Cells http://www.peprotech.com/
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sakabe, H.
Right arrow Articles by Sonoda, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sakabe, H.
Right arrow Articles by Sonoda, Y.
Stem Cells, Vol. 15, No. 1, 73-81, January 1997
© 1997 AlphaMed Press

Functional Differences between Subpopulations of Mobilized Peripheral Blood-Derived CD34+ Cells Expressing Different Levels of HLA-DR, CD33, CD38 and c-kit Antigens

Hideaki Sakabea,d, Yoshikazu Ohmizonob, Shigeatsu Tanimukaic, Takafumi Kimurad, Kazuhiro J. Morie, Tatsuo Abed, Yoshiaki Sonodad

a Second Department of Internal Medicine, Shiga University of Medical Science,
b Department of Pediatrics,
c Second Department of Surgery,
d Department of Hygiene, Kyoto Prefectural University of Medicine, Kyoto, Japan; Department of Biology, Faculty of Science, Niigata University, Niigata, Japan

Key Words. PBSCT • G-CSF • CD34+ • CD33 • CD38 • c-kit • LTC-IC

Dr. Yoshiaki Sonoda, Department of Hygiene, Kyoto Prefectural University of Medicine, Kawaramachi-Hirokoji, Kamigyoku, Kyoto 602, Japan.

We have investigated the functional characteristics of peripheral blood-derived CD34+ cells mobilized by a combination of chemotherapy and G-CSF (mobilized peripheral blood-derived [MPB] CD34+ cells). In this study, subpopulations of MPB CD34+ cells have been directly compared in clonal cultures, long-term cultures with bone marrow (BM) stromal cells, and single-cell cultures. MPB CD34+ cells could be subdivided by expression levels of HLA-DR (DR), CD38, CD33 and c-kit antigens. The majority of MPB CD34+ cells expressed DR and CD38 antigens. In contrast, approximately 60% and 20% of the MPB CD34+ cells expressed CD33 and c-kit antigens, respectively. Interestingly, MPB CD34+ cells can be subdivided into three fractions which express high, low or negative levels of c-kit receptor. All types of committed progenitors were observed in populations of CD34+DR+, CD34+DR, CD34+CD33, CD34+CD38+ and CD34+ c-kitlow cells. Colony forming unit-granulocyte/macrophage was highly enriched in the population of CD34+CD33+ cells, whereas BFU-E was highly enriched in the population of CD34+ c-kithigh cells. In the population of CD34+CD38 cells, however, a few myeloid progenitors were detected. In addition, limiting dilution analyses clearly showed that the long-term culture-initiating cell (LTC-IC) is enriched in the populations of CD34+DR, CD34+CD33 and CD34+c-kit– or low cells, but very few in CD34+ c-kithigh cells, and that CD38 antigen is not a useful marker for the enrichment of LTC-IC derived from MPB CD34+ cells. Moreover, single cell clone sorting experiments clearly demonstrated the functional differences between CD34+CD38+ and CD34+CD38 cells as well as CD34+ cells expressing different levels of c-kit receptor. Our results suggest that an immunophenotype of LTC-IC is different between BM-, cord blood- and MPB-derived CD34+ cells and that primitive and committed progenitors existing in these sources may be functionally different.




This article has been cited by other articles:


Home page
Stem CellsHome page
C. Hart, D. Drewel, G. Mueller, J. Grassinger, M. Zaiss, L. A. Kunz-Schughart, R. Andreesen, A. Reichle, E. Holler, and B. Hennemann
Expression and Function of Homing-Essential Molecules and Enhanced In Vivo Homing Ability of Human Peripheral Blood-Derived Hematopoietic Progenitor Cells after Stimulation with Stem Cell Factor
Stem Cells, July 1, 2004; 22(4): 580 - 589.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Y. Cui, J. Golob, E. Kelleher, Z. Ye, D. Pardoll, and L. Cheng
Targeting transgene expression to antigen-presenting cells derived from lentivirus-transduced engrafting human hematopoietic stem/progenitor cells
Blood, January 15, 2002; 99(2): 399 - 408.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
T. Kimura, H. Sakabe, S. Tanimukai, T. Abe, Y. Urata, K. Yasukawa, A. Okano, T. Taga, H. Sugiyama, T. Kishimoto, et al.
Simultaneous Activation of Signals Through gp130, c-kit, and Interleukin-3 Receptor Promotes a Trilineage Blood Cell Production in the Absence of Terminally Acting Lineage-Specific Factors
Blood, December 15, 1997; 90(12): 4767 - 4778.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
STEM CELLS THE ONCOLOGIST CME ALPHAMED PRESS JOURNALS
http://www.peprotech.com/
Copyright © 1997 by AlphaMed Press.